InsiderClue
Insiders · Profile

Epperly Melissa B,

Director at Roivant Sciences · Chief Financial Officer at Zentalis Pharmaceuticals. Filing since 7 Apr 2020. CIK 0001807359

ROIV Roivant Sciences Ltd. Director · 4 trades ZNTL Zentalis Pharmaceuticals, Inc. Chief Financial Officer · 21 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ROIV Roivant Sciences Ltd.
1 Oct 2026
Director
Sold on a plan
17,750
$640.86K
54.3%
ROIV Roivant Sciences Ltd.
15 Sep 2026
Director
Sold on a plan
4,938
$196.23K
33.3%
ROIV Roivant Sciences Ltd.
29 Jun 2026
Director
Sold on a plan
17,750
$610.25K
51.9%
ROIV Roivant Sciences Ltd.
16 Mar 2026
Director
Sold at will
41,861
$1.20M
72.6%
ZNTL Zentalis Pharmaceuticals, Inc.
12 Feb 2024
Chief Financial Officer
Sold at will
2,573
$29.44K
0.6%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Feb 2024
Chief Financial Officer
Sold at will
8,669
$100.04K
1.9%
ZNTL Zentalis Pharmaceuticals, Inc.
4 Oct 2023
Chief Financial Officer
Sold on a plan
5,482
$106.93K
1.4%
ZNTL Zentalis Pharmaceuticals, Inc.
14 Feb 2023
Chief Financial Officer
Sold, plan not stated
5,227
$104.41K
1.3%
ZNTL Zentalis Pharmaceuticals, Inc.
13 Feb 2023
Chief Financial Officer
Sold, plan not stated
2,624
$53.59K
0.7%
ZNTL Zentalis Pharmaceuticals, Inc.
4 Apr 2022
Chief Financial Officer
Sold, plan not stated
17,080
$855.52K
6.5%
ZNTL Zentalis Pharmaceuticals, Inc.
23 Feb 2022
Chief Financial Officer
Sold, plan not stated
1,913
$93.92K
0.7%
ZNTL Zentalis Pharmaceuticals, Inc.
19 Aug 2021
Chief Financial Officer
Bought
8,285
$430.80K
3.2%
ZNTL Zentalis Pharmaceuticals, Inc.
18 Aug 2021
Chief Financial Officer
Bought
1,326
$68.95K
0.5%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Jul 2021
Chief Financial Officer
Sold, plan not stated
3,083
$158.05K
1.2%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Jun 2021
Chief Financial Officer
Sold, plan not stated
3,083
$166.64K
1.2%
ZNTL Zentalis Pharmaceuticals, Inc.
3 May 2021
Chief Financial Officer
Sold, plan not stated
3,083
$182.63K
1.2%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Apr 2021
Chief Financial Officer
Sold, plan not stated
17,107
$742.32K
6.0%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Mar 2021
Chief Financial Officer
Sold, plan not stated
3,083
$128.48K
1.1%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Feb 2021
Chief Financial Officer
Sold, plan not stated
3,083
$115.80K
1.1%
ZNTL Zentalis Pharmaceuticals, Inc.
4 Jan 2021
Chief Financial Officer
Sold, plan not stated
3,083
$160.03K
1.1%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Dec 2020
Chief Financial Officer
Sold, plan not stated
6,464
$345.96K
2.3%
ZNTL Zentalis Pharmaceuticals, Inc.
4 Dec 2020
Chief Financial Officer
Sold, plan not stated
7,220
$368.10K
2.5%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Dec 2020
Chief Financial Officer
Sold, plan not stated
3,083
$158.68K
1.0%
ZNTL Zentalis Pharmaceuticals, Inc.
23 Nov 2020
Chief Financial Officer
Sold, plan not stated
3,083
$143.61K
1.0%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Apr 2020
Chief Financial Officer
Bought
20,000
$360.00K
7.2%
25 decisions on file.